Elanco Animal Health Inc

Company Snapshot
2500 Innovation Way
Greenfield, IN 46140
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 9,800
https://www.elanco.com
Please select from the dropdown
  1. Executive Compensation
  2. > Elanco Animal Health Inc
Company Financials

2021
2022
2023
Gross Profit
$2,631,000,000
$2,498,000,000
$2,486,000,000
Operating Income
$302,000,000
$384,000,000
$326,000,000
Net Income
-$472,000,000
-$78,000,000
-$1,231,000,000
2021
Gross Profit
$2,631,000,000
Operating Income
$302,000,000
Net Income
-$472,000,000
2022
Gross Profit
$2,498,000,000
Operating Income
$384,000,000
Net Income
-$78,000,000
2023
Gross Profit
$2,486,000,000
Operating Income
$326,000,000
Net Income
-$1,231,000,000
The above data on Elanco Animal Health Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Jeffrey Simmons
President, Chief Executive Officer and Director
$2,432,400
$11,200,008
$30,761
$13,663,169
Jeffrey Simmons
$13,663,169
President, Chief Executive Officer and Director
Todd Young
Executive Vice President and Chief Financial Officer
$1,079,405
$2,615,020
$32,296
$3,726,721
Todd Young
$3,726,721
Executive Vice President and Chief Financial Officer
Ellen de Brabander
Executive Vice President Innovation and Regulatory Affairs
$1,102,239
$2,542,015
$39,480
$3,683,734
Ellen de Brabander
$3,683,734
Executive Vice President Innovation and Regulatory Affairs
Ramiro Cabral
Executive Vice President and President of Elanco International
$919,376
$1,700,016
$31,362
$2,650,754
Ramiro Cabral
$2,650,754
Executive Vice President and President of Elanco International
Timothy Bettington
Executive Vice President Corporate Strategy and Market Development
$856,119
$1,000,008
$197,835
$2,053,962
Timothy Bettington
$2,053,962
Executive Vice President Corporate Strategy and Market Development
Elanco Animal Health Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us